...
首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Cichoric Acid Ameliorates Monosodium Urate-Induced Inflammatory Response by Reducing NLRP3 Inflammasome Activation via Inhibition of NF- k B Signaling Pathway
【24h】

Cichoric Acid Ameliorates Monosodium Urate-Induced Inflammatory Response by Reducing NLRP3 Inflammasome Activation via Inhibition of NF- k B Signaling Pathway

机译:通过减少NF-K B信号通路的抑制,CICHOC酸通过减少NLRP3炎性激活来改善单钠尿液诱导的炎症反应

获取原文
           

摘要

Gouty arthritis is characterized by the deposition of monosodium urate (MSU) within synovial joints and tissues due to increased urate concentrations. Here, we elucidated the role of the natural compound cichoric acid (CA) on the MSU crystal-stimulated inflammatory response. The THP-1-derived macrophages (THP-Ms) were pretreated with CA and then stimulated with MSU suspensions. The protein levels of p65 and I κ B α , the activation of the NF- κ B signaling pathway by measuring the expression of its downstream inflammatory cytokines, and the activity of NLRP3 inflammasome were measured by western blotting and ELISA. CA treatment markedly inhibited the degradation of I κ B α and the activation of NF- κ B signaling pathway and reduced the levels of its downstream inflammatory genes such as IL-1 β , TNF- α , COX-2, and PGE2 in the MSU-stimulated THP-M cells. Therefore, we infer that CA effectively alleviated MSU-induced inflammation by suppressing the degradation of I κ B α , thereby reducing the activation of the NF- κ B signaling pathway and the NLRP3 inflammasome. These results suggest that CA could be a novel therapeutic strategy in averting acute episodes of gout.
机译:痛风关节炎的特征在于由于尿酸盐浓度增加,在滑膜接头和组织中沉积尿酸盐(MSU)。在这里,我们阐明了天然化合物CICHICAN酸(CA)对MSU晶体刺激的炎症反应的作用。用Ca预处理THP-1衍生的巨噬细胞(THP-MS),然后用MSU悬浮液刺激。 P65和IκBα的蛋白质水平,通过测量其下游炎性细胞因子的表达,通过蛋白质印迹和ELISA测量NF-κB信号传导途径的激活,以及NLRP3炎性组的活性。 Ca治疗显着抑制Iκbα的降解和NF-κB信号传导途径的激活,并降低了MSU中的下游炎症基因的水平,如IL-1β,TNF-α,COX-2和PGE2 -Stimulated的THP-M细胞。因此,我们通过抑制Iκbα的降解,可以有效地减轻了MSU诱导的MSU诱导的炎症,从而减少了NF-κB信号通路和NLRP3炎症的活化。这些结果表明CA可以是避免痛风急性发作的新型治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号